Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Microsoft
MSFT
5
NVIDIA
NVDA
US Stock MarketDetailed Quotes
Pacira BioSciences (PCRX)
- 20.830
- +0.060+0.29%
Trading Jan 23 10:02 ET
896.13MMarket Cap44.32P/E (TTM)
21.085High20.620Low55.07KVolume20.730Open20.770Prev Close1.15MTurnover0.13%Turnover RatioLossP/E (Static)43.02MShares27.64052wk High1.18P/B882.26MFloat Cap18.80052wk Low--Dividend TTM42.36MShs Float121.950Historical High--Div Yield TTM2.24%Range %6.160Historical Low20.866Avg Price1Lot Size
Pacira BioSciences (PCRX) Income Statement
Quarterly+Annual
YOY
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 6.49%179.52M | 1.73%181.1M | 1.08%168.92M | 3.85%700.97M | 3.32%187.25M | 2.83%168.57M | 5.05%178.02M | 4.23%167.12M | 1.22%674.98M | 5.40%181.24M |
| Operating revenue | 6.49%179.52M | 1.73%181.1M | 1.08%168.92M | 3.85%700.97M | 3.32%187.25M | 2.83%168.57M | 5.05%178.02M | 4.23%167.12M | 1.22%674.98M | 5.40%181.24M |
| Cost of revenue | -11.80%34.28M | -7.67%40.87M | -27.65%34.31M | -7.71%170.43M | -16.37%39.89M | -2.23%38.86M | -8.18%44.26M | -3.27%47.42M | -7.34%184.67M | -22.97%47.69M |
| Gross profit | 11.97%145.24M | 4.84%140.23M | 12.46%134.62M | 8.20%530.54M | 10.34%147.37M | 4.46%129.71M | 10.31%133.76M | 7.53%119.7M | 4.87%490.31M | 21.37%133.55M |
| Operating expense | 22.57%132.09M | 27.55%131.1M | 20.90%126.44M | 7.44%432.96M | 18.32%117.83M | 4.52%107.76M | 4.89%102.79M | 2.23%104.59M | 1.61%402.99M | 3.96%99.59M |
| Selling and administrative expenses | 23.49%91.8M | 30.02%88.58M | 20.48%86.78M | 9.15%294.1M | 20.99%79.61M | 9.40%74.33M | 5.05%68.13M | 1.67%72.03M | 5.86%269.44M | 2.86%65.8M |
| -Selling and marketing expense | 35.38%58.47M | 30.52%50.96M | 40.92%55.57M | 12.40%172.02M | 40.86%50.34M | 12.89%43.19M | 4.23%39.05M | -5.16%39.44M | --153.04M | --35.74M |
| -General and administrative expense | 7.01%33.33M | 29.35%37.61M | -4.25%31.21M | 4.88%122.08M | -2.63%29.27M | 4.90%31.14M | 6.17%29.08M | 11.37%32.59M | --116.4M | --30.06M |
| Research and development costs | 35.92%25.97M | 38.66%28.2M | 38.95%25.34M | 6.98%81.58M | 22.78%23.9M | -8.29%19.1M | 8.04%20.34M | 6.41%18.24M | -10.07%76.26M | 11.19%19.46M |
| Depreciation amortization depletion | 0.00%14.32M | 0.00%14.32M | 0.00%14.32M | 0.00%57.29M | 0.00%14.32M | 0.00%14.32M | 0.00%14.32M | 0.00%14.32M | 0.00%57.29M | 0.00%14.32M |
| -Depreciation and amortization | 0.00%14.32M | 0.00%14.32M | 0.00%14.32M | 0.00%57.29M | 0.00%14.32M | 0.00%14.32M | 0.00%14.32M | 0.00%14.32M | 0.00%57.29M | 0.00%14.32M |
| Operating profit | -40.08%13.15M | -70.51%9.13M | -45.90%8.18M | 11.74%97.57M | -13.05%29.53M | 4.14%21.95M | 33.15%30.98M | 67.65%15.12M | 23.12%87.32M | 138.49%33.97M |
| Net non-operating interest income expense | 436.57%4.26M | -63.82%313K | 294.38%2.32M | 135.21%3.12M | 2,264.86%875K | 213.61%793K | 149.32%865K | 109.11%587K | 74.99%-8.86M | 100.45%37K |
| Non-operating interest income | 55.67%8.53M | 5.45%5.01M | 76.66%6.9M | 72.05%19.69M | 62.19%5.56M | 98.19%5.48M | 124.96%4.75M | 24.22%3.9M | 151.96%11.44M | 22.98%3.43M |
| Non-operating interest expense | -5.09%3.65M | 23.23%3.85M | 41.75%3.74M | -22.36%13.44M | 41.84%3.83M | 38.40%3.85M | -1.67%3.12M | -69.54%2.64M | -51.34%17.31M | -71.83%2.7M |
| Total other finance cost | -25.48%626K | 11.27%849K | 24.08%845K | 4.47%3.13M | 23.50%846K | 22.99%840K | 10.42%763K | -27.32%681K | -31.91%3M | -52.56%685K |
| Other net income (expense) | 95.12%-7.88M | -339.73%-11.37M | 13.39%-1.79M | -877.33%-163.8M | -1,625.44%-4.88M | -4,177.37%-161.6M | -70.97%4.74M | 92.90%-2.06M | 24.47%-16.76M | 98.82%-283K |
| Special income (charges) | 95.19%-7.77M | -113.26%-634K | -225.12%-6.19M | -886.04%-163.43M | -505.26%-4.83M | -4,711.59%-161.48M | -71.21%4.78M | 93.45%-1.9M | -52.01%-16.57M | 96.69%-798K |
| -Less：Restructuring and merger&acquisition | 330.63%4.07M | -76.82%634K | -142.72%-813K | 2,288.07%7.7M | 505.26%4.83M | -152.62%-1.77M | 116.46%2.74M | -84.28%1.9M | -103.23%-352K | -96.69%798K |
| -Less:Impairment of capital assets | -84.15%25.87M | ---- | ---- | --163.24M | --0 | --163.24M | ---- | ---- | --0 | --0 |
| -Less:Other special charges | ---22.17M | ---- | --7M | -144.42%-7.52M | --0 | ---- | ---7.52M | ---- | --16.93M | --0 |
| Other non- operating income (expenses) | 9.84%-110K | -27,435.90%-10.74M | 2,867.92%4.4M | -100.54%-373K | -110.29%-53K | 71.09%-122K | 85.50%-39K | -1,490.00%-159K | 98.35%-186K | 535.80%515K |
| Income before tax | 106.86%9.52M | -105.27%-1.93M | -36.17%8.71M | -202.28%-63.11M | -24.30%25.53M | -936.43%-138.86M | -3.35%36.58M | 151.52%13.64M | 363.85%61.7M | 286.63%33.72M |
| Income tax | -11.24%4.09M | -83.50%2.92M | -16.46%3.89M | 84.61%36.45M | 7.18%9.49M | -19.73%4.61M | 46.37%17.7M | 167.18%4.66M | 857.42%19.75M | 211.10%8.85M |
| Net income | 103.79%5.43M | -125.66%-4.85M | -46.41%4.81M | -337.30%-99.56M | -35.50%16.04M | -1,421.29%-143.47M | -26.69%18.89M | 145.96%8.98M | 163.72%41.96M | 346.19%24.87M |
| Net income continuous Operations | 103.79%5.43M | -125.66%-4.85M | -46.41%4.81M | -337.30%-99.56M | -35.50%16.04M | -1,421.29%-143.47M | -26.69%18.89M | 145.96%8.98M | 163.72%41.96M | 346.19%24.87M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 103.79%5.43M | -125.66%-4.85M | -46.41%4.81M | -337.30%-99.56M | -35.50%16.04M | -1,421.29%-143.47M | -26.69%18.89M | 145.96%8.98M | 163.72%41.96M | 346.19%24.87M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 103.79%5.43M | -125.66%-4.85M | -46.41%4.81M | -337.30%-99.56M | -35.50%16.04M | -1,421.29%-143.47M | -26.69%18.89M | 145.96%8.98M | 163.72%41.96M | 346.19%24.87M |
| Basic earnings per share | 103.86%0.12 | -126.83%-0.11 | -47.37%0.1 | -336.26%-2.15 | -35.19%0.35 | -1,452.17%-3.11 | -26.79%0.41 | 144.19%0.19 | 160.00%0.91 | 345.45%0.54 |
| Diluted earnings per share | 103.86%0.12 | -128.21%-0.11 | -47.37%0.1 | -341.57%-2.15 | -34.62%0.34 | -1,452.17%-3.11 | -23.53%0.39 | 144.19%0.19 | 161.76%0.89 | 336.36%0.52 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Market Insights
Nancy Pelosi Portfolio Nancy Pelosi Portfolio
Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns. Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns.
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec
今日熱門
Dec 11, 2025 03:27
December FOMC Interest Rate Meeting
牛牛課堂
Dec 19, 2025 12:28
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?